Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

34.340
+0.3401.00%
Volume:5.89M
Turnover:202.62M
Market Cap:208.24B
PE:31.55
High:34.680
Open:34.000
Low:33.420
Close:34.000
52wk High:43.939
52wk Low:27.882
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:0.54
T/O Rate:0.10%
Dividend:0.43
Dividend Rate:1.26%
EPS(LYR):1.089
ROE:19.40%
ROA:9.08%
PB:4.71
PE(LYR):31.55
PS:11.19

Loading ...

Hansoh Pharmaceutical - Nmpa Grants Breakthrough-Therapy Designation to Hs-10504 Tablets for Nsclc

THOMSON REUTERS
·
May 21

Johnson & Johnson says nipocalimab approved in China

Reuters
·
May 21

Hansoh Pharmaceutical Group Stock Sheds 1.1% in Hong Kong

Dow Jones
·
May 20

Hansoh Pharmaceutical Group Stock Falls 2.8% in Hong Kong

Dow Jones
·
May 18

HANSOH PHARMA Announces Appointment of New Joint Company Secretary and Authorized Representative

Stock News
·
May 15

Hansoh Pharma Reshuffles Company Secretariat: New Joint Company Secretary and Authorized Representative Appointed

Bulletin Express
·
May 15

Hansoh Pharma names Zeng Zhao joint company secretary after Lee Leong Yin resigns

Reuters
·
May 15

Hansoh Pharmaceutical Group Stock Sheds 1.3% in Hong Kong

Dow Jones
·
May 14

Hansoh Pharma Gets China Nod for Trial of Tumor Drug

MT Newswires Live
·
May 14

Hansoh Pharma Receives NMPA Green Light to Launch HS-10541 Clinical Trials for KRAS G12C Solid Tumors

Bulletin Express
·
May 13

HANSOH PHARMA's Novel Drug HS-10541 Tablets Receive Clinical Trial Approval from NMPA

Stock News
·
May 13

Hansoh Pharma wins China approval to start HS-10541 trial in KRAS G12C tumors

Reuters
·
May 13

Hansoh Pharmaceutical - Hs-10541 Tablets Obtain Clinical Trial Approval From China's Nmpa

THOMSON REUTERS
·
May 13

Hansoh Pharmaceutical Group Stock Advances 1.2% in Hong Kong

Dow Jones
·
May 11

HANSOH PHARMA's B7-H3-Targeting ADC HS-20093 Designated as Breakthrough Therapy for Esophageal Squamous Cell Carcinoma

Stock News
·
May 11

Hansoh says China NMPA grants breakthrough therapy status for HS-20093 in esophageal cancer

Reuters
·
May 11

Hansoh Pharmaceutical - Nmpa Grants Breakthrough-Therapy Designation to Hansoh Pharma's Hs-20093 for Escc

THOMSON REUTERS
·
May 11

Hansoh Pharmaceutical Group Stock Slips 3.8% in Hong Kong

Dow Jones
·
May 08

AI Frenzy Shifts from Hardware to Applications, Musk-Related Concepts Gain Traction

Stock News
·
May 07

Hansoh Pharmaceutical Group SEHK 3692 Valuation After New Breakthrough Therapy And Hypertension Trial Approvals

Simply Wall St.
·
May 05